These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

96 related items for PubMed ID: 8152803

  • 1. The oncogenic transcription factor IRF-2 possesses a transcriptional repression and a latent activation domain.
    Yamamoto H, Lamphier MS, Fujita T, Taniguchi T, Harada H.
    Oncogene; 1994 May; 9(5):1423-8. PubMed ID: 8152803
    [Abstract] [Full Text] [Related]

  • 2. Transcription factor IRF-2 exerts its oncogenic phenotype through the DNA binding/transcription repression domain.
    Nguyen H, Mustafa A, Hiscott J, Lin R.
    Oncogene; 1995 Aug 03; 11(3):537-44. PubMed ID: 7630638
    [Abstract] [Full Text] [Related]

  • 3. Interferon-gamma regulation of the human mimecan promoter.
    Tasheva ES, Conrad GW.
    Mol Vis; 2003 Jun 30; 9():277-87. PubMed ID: 12835654
    [Abstract] [Full Text] [Related]

  • 4. Identification of the secretory leukocyte protease inhibitor (SLPI) as a target of IRF-1 regulation.
    Nguyen H, Teskey L, Lin R, Hiscott J.
    Oncogene; 1999 Sep 23; 18(39):5455-63. PubMed ID: 10498899
    [Abstract] [Full Text] [Related]

  • 5. The LAZ3/BCL6 oncogene encodes a sequence-specific transcriptional inhibitor: a novel function for the BTB/POZ domain as an autonomous repressing domain.
    Deweindt C, Albagli O, Bernardin F, Dhordain P, Quief S, Lantoine D, Kerckaert JP, Leprince D.
    Cell Growth Differ; 1995 Dec 23; 6(12):1495-503. PubMed ID: 9019154
    [Abstract] [Full Text] [Related]

  • 6. Identification of the lysyl oxidase gene as target of the antioncogenic transcription factor, IRF-1, and its possible role in tumor suppression.
    Tan RS, Taniguchi T, Harada H.
    Cancer Res; 1996 May 15; 56(10):2417-21. PubMed ID: 8625321
    [Abstract] [Full Text] [Related]

  • 7. Targeted disruption of IRF-1 or IRF-2 results in abnormal type I IFN gene induction and aberrant lymphocyte development.
    Matsuyama T, Kimura T, Kitagawa M, Pfeffer K, Kawakami T, Watanabe N, Kündig TM, Amakawa R, Kishihara K, Wakeham A.
    Cell; 1993 Oct 08; 75(1):83-97. PubMed ID: 8402903
    [Abstract] [Full Text] [Related]

  • 8. Direct triggering of the type I interferon system by virus infection: activation of a transcription factor complex containing IRF-3 and CBP/p300.
    Yoneyama M, Suhara W, Fukuhara Y, Fukuda M, Nishida E, Fujita T.
    EMBO J; 1998 Feb 16; 17(4):1087-95. PubMed ID: 9463386
    [Abstract] [Full Text] [Related]

  • 9. HiNF-D (CDP-cut/CDC2/cyclin A/pRB-complex) influences the timing of IRF-2-dependent cell cycle activation of human histone H4 gene transcription at the G1/S phase transition.
    Aziz F, van Wijnen AJ, Stein JL, Stein GS.
    J Cell Physiol; 1998 Dec 16; 177(3):453-64. PubMed ID: 9808153
    [Abstract] [Full Text] [Related]

  • 10. Protein-protein and DNA-protein interactions affect the activity of lymphoid-specific IFN regulatory factors.
    Meraro D, Hashmueli S, Koren B, Azriel A, Oumard A, Kirchhoff S, Hauser H, Nagulapalli S, Atchison ML, Levi BZ.
    J Immunol; 1999 Dec 15; 163(12):6468-78. PubMed ID: 10586038
    [Abstract] [Full Text] [Related]

  • 11. Differential expression and distinct functions of IFN regulatory factor 4 and IFN consensus sequence binding protein in macrophages.
    Marecki S, Atchison ML, Fenton MJ.
    J Immunol; 1999 Sep 01; 163(5):2713-22. PubMed ID: 10453013
    [Abstract] [Full Text] [Related]

  • 12. The role of the interferon regulatory factors, IRF-1 and IRF-2, in LPS-induced cyclooxygenase-2 (COX-2) expression in vivo and in vitro.
    Zhang S, Thomas K, Blanco JC, Salkowski CA, Vogel SN.
    J Endotoxin Res; 2002 Sep 01; 8(5):379-88. PubMed ID: 12537697
    [Abstract] [Full Text] [Related]

  • 13. Conserved high-affinity NF-kappa B binding site in the interferon regulatory factor-1 promoter is not occupied by NF-kappa B in vivo and is transcriptionally inactive.
    Rein T, Schreck R, Willenbrink W, Neubert WJ, Zorbas H, Bäuerle PA.
    J Inflamm; 1995 Sep 01; 45(4):269-82. PubMed ID: 8867671
    [Abstract] [Full Text] [Related]

  • 14. The interferon regulatory factors 1 and 2 bind to a segment of the human c-myb first intron: possible role in the regulation of c-myb expression.
    Manzella L, Gualdi R, Perrotti D, Nicolaides NC, Girlando G, Giuffrida MA, Messina A, Calabretta B.
    Exp Cell Res; 2000 Apr 10; 256(1):248-56. PubMed ID: 10739671
    [Abstract] [Full Text] [Related]

  • 15. IRF-1 and IRF-2 as regulators of the interferon system and cell growth.
    Taniguchi T.
    Indian J Biochem Biophys; 1995 Oct 10; 32(5):235-9. PubMed ID: 8713742
    [Abstract] [Full Text] [Related]

  • 16. Preferential binding sites for interferon regulatory factors 3 and 7 involved in interferon-A gene transcription.
    Morin P, Bragança J, Bandu MT, Lin R, Hiscott J, Doly J, Civas A.
    J Mol Biol; 2002 Mar 08; 316(5):1009-22. PubMed ID: 11884139
    [Abstract] [Full Text] [Related]

  • 17. Molecular characterization of celtix-1, a bromodomain protein interacting with the transcription factor interferon regulatory factor 2.
    Staal A, Enserink JM, Stein JL, Stein GS, van Wijnen AJ.
    J Cell Physiol; 2000 Nov 08; 185(2):269-79. PubMed ID: 11025449
    [Abstract] [Full Text] [Related]

  • 18. FEV acts as a transcriptional repressor through its DNA-binding ETS domain and alanine-rich domain.
    Maurer P, T'Sas F, Coutte L, Callens N, Brenner C, Van Lint C, de Launoit Y, Baert JL.
    Oncogene; 2003 May 22; 22(21):3319-29. PubMed ID: 12761502
    [Abstract] [Full Text] [Related]

  • 19. A dominant negative mutant of an IFN regulatory factor family protein inhibits both type I and type II IFN-stimulated gene expression and antiproliferative activity of IFNs.
    Thornton AM, Ogryzko VV, Dent A, Sharf R, Levi BZ, Kanno Y, Staudt LM, Howard BH, Ozato K.
    J Immunol; 1996 Dec 01; 157(11):5145-54. PubMed ID: 8943426
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.